UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009797 |
|---|---|
| Receipt number | R000011103 |
| Scientific Title | Phase II study of bendamustine, rituximab and cytarabine for patients with relapsed or refractory follicular lymphoma or mantle cell lymphoma |
| Date of disclosure of the study information | 2013/01/17 |
| Last modified on | 2022/03/01 22:14:56 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/01/17 16:56:38 | ||
| 2 | Update | 2013/05/04 14:46:15 | Acronym Acronym |
|
| 3 | Update | 2014/02/02 00:40:28 | TEL TEL TEL Tel1 |
|
| 4 | Update | 2014/02/02 00:45:12 | Organization Division name Organization |
|
| 5 | Update | 2015/01/17 20:51:07 | URL releasing protocol |
|
| 6 | Update | 2016/11/04 22:01:05 | Name of primary person or sponsor Organization Institutions |
|
| 7 | Update | 2019/11/03 10:23:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of person sending information Email1 Organization Organization Address Address Tel |
|
| 8 | Update | 2019/11/03 10:34:49 | Date of IRB Last follow-up date |
|
| 9 | Update | 2021/07/26 04:22:06 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 10 | Update | 2021/07/26 04:23:12 | Number of participants that the trial has enrolled |
|
| 11 | Update | 2022/03/01 22:14:56 | URL releasing protocol Publication of results URL related to results and publications Date of the first journal publication of results |
